Independent Franchise Partners
US Equity Fund
Independent Franchise Partners Reckitt Benckiser Group PLC stake
total: 60
US Equity Fund RBGPF trades
- Total transactions:
- 9
- New positions:
- 1
- Added:
- 3
- Reduced:
- 5
- Held since:
- 2024 Q1
- Held for:
- 9 quarters
- Latest activity:
- 2026 Q1
According to 2026 Q1 report, Independent Franchise Partners holds 378,656 Reckitt Benckiser Group PLC (RBGPF) shares with a market value of roughly $25.70M accounting for 1.74% of the overall portfolio. To date, the estimated cost basis is nearly $58.36 for "buy" trades and estimated average "sell" price is $64.18. US Equity Fund first purchased RBGPF in 2024 Q1, initially acquiring about 1.04M shares. Since the initial investment in Reckitt Benckiser Group PLC (RBGPF), US Equity Fund has made 8 more transactions.
When did Independent Franchise Partners buy Reckitt Benckiser Group PLC (RBGPF)?
Independent Franchise Partners first invested in Reckitt Benckiser Group PLC (RBGPF) in 2024 Q1 at the reported quarter-end price of $56.95 per share.
What's the cost basis of US Equity Fund's RBGPF stake?
The estimated cost basis for Reckitt Benckiser Group PLC (RBGPF) stake is around $58.36 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $58.36
- Weighted AVG sell price:
- $64.18
Independent Franchise Partners's historical trades in Reckitt Benckiser Group PLC
9 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
1.74%
|
378,656
|
$67.86
|
$25,696,601
|
-1.67% (-6,423)
|
-0.03%
|
|
2025 Q4
|
1.99%
|
385,079
|
$80.90
|
$31,154,419
|
-8.53% (-35,904)
|
-0.18%
|
|
2025 Q3
|
1.98%
|
420,983
|
$76.90
|
$32,374,175
|
+5.22% (+20,891)
|
+0.1%
|
|
2025 Q2
|
1.88%
|
400,092
|
$68.01
|
$27,212,182
|
-46.07% (-341,846)
|
-1.67%
|
|
2025 Q1
|
3.59%
|
741,938
|
$67.56
|
$50,124,237
|
+16.75% (+106,437)
|
+0.52%
|
|
2024 Q4
|
3.50%
|
635,501
|
$60.50
|
$38,450,562
|
-38.80% (-402,942)
|
-1.24%
|
|
2024 Q3
|
3.24%
|
1,038,443
|
$61.19
|
$63,544,616
|
+3.95% (+39,431)
|
+0.12%
|
|
2024 Q2
|
2.88%
|
999,012
|
$54.13
|
$54,075,287
|
-4.31% (-45,037)
|
-0.13%
|
|
2024 Q1
|
3.05%
|
1,044,049
|
$56.95
|
$59,456,724
|
new
|
+3.05%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.